Insulin
Sold as Apidra, Actrapid hm (ge)
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 2
- Registrations
- 2
- Schedule source
- SAHPRA documentation
Applicants and registrations
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Apidra EACH 1,0 ml SOLUTION CONTAINS :INSULIN GLULISINE EQUIMOLAR TO INSULIN 100,0 iu | 1 mLSolution for injection | A380506A38/21.1/0506Approved 10 December 2022 | Registered | S3 | PIPIL |
| Actrapid hm (ge) EACH 1 ml CONTAINS INSULIN 100 U | 100 unitsSolution for injection. | W0288W/21.1/288Approved 17 June 2021 | Registered | S3 | PIPIL |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Insulin glulisine equivalent to insulin
S3: Insulin
Consolidated Schedules 06 July 2026, line 3794
Pharmacological class: Insulin preparations. (class 21.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Apidra, Sanofi-aventis South Africa (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.